Evidence map›Paper›PMID 18787689›Full record

ArticlePLoS pathogens2008

Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response.

Fredrik Kahn, Matthias Mörgelin, Oonagh Shannon, Anna Norrby-Teglund, Heiko Herwald, Anders I Olin, Lars Björck

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Group AFrontiers in cardiovascular medicine · 2021
    Article
  7. Observational
  8. Article
  9. Article
  10. Fisetin LowersFrontiers in microbiology · 2018
    Article
  11. HP1330 Contributes toFrontiers in immunology · 2017
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Streptococcus adherence and colonization.Microbiology and molecular biology reviews : MMBR · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Fredrik KahnDepartment of Clinical Sciences, Division of Infection Medicine, Lund University, BMC, B14, Lund, Sweden. fredrik.kahn@med.lu.se
Matthias Mörgelin
Oonagh Shannon
Anna Norrby-Teglund
Heiko Herwald
Anders I Olin
Lars Björck
Lund University · SEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcal toxic shock syndrome (STSS) caused by Streptococcus pyogenes is a clinical condition with a high mortality rate despite modern intensive care. A key feature of STSS is excessive plasma leakage leading to hypovolemic hypotension, disturbed microcirculation and multiorgan failure. Previous work has identified a virulence mechanism in STSS where M1 protein of S. pyogenes forms complexes with fibrinogen that activate neutrophils to release heparin-binding protein (HBP), an inducer of vascular leakage. Here, we report a marked inter-individual difference in the response to M1 protein-induced HBP release, a difference found to be related to IgG antibodies directed against the central region of the M1 protein. To elicit massive HBP release, such antibodies need to be part of the M1 protein-fibrinogen complexes. The data add a novel aspect to bacterial pathogenesis where antibodies contribute to the severity of disease by promoting a pathologic inflammatory response.

Indexed as

Antibodies, BacterialAntigens, BacterialBacterial Outer Membrane ProteinsCarrier ProteinsCells, CulturedFibrinogenHumansImmunoglobulin GInflammationNeutrophilsStreptococcal InfectionsStreptococcus pyogenesAntibodies, BacterialAntigens, BacterialBacterial Outer Membrane ProteinsCarrier ProteinsFibrinogenImmunoglobulin Gstreptococcal M protein

Identifiers

PMID18787689
PMCPMC2522270
OpenAlexW2079128528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.